These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29797206)

  • 1. Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in Mice.
    Wang S; Wang J; Liu Y; Li H; Wang Q; Huang Z; Liu W; Shi P
    Biol Trace Elem Res; 2019 Jan; 187(1):192-201. PubMed ID: 29797206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis.
    Wang S; Wang J; Zhang X; Hu L; Fang Z; Huang Z; Shi P
    Biometals; 2016 Oct; 29(5):881-92. PubMed ID: 27497686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
    Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
    Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
    Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
    Ma L; Wang Y; Chen X; Zhao L; Guo Y
    Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
    Patel TP; Rawal K; Soni S; Gupta S
    Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
    Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
    FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
    Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
    Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
    Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
    Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis.
    Sánchez-Garrido MA; Chico Y; González R; Ranchal I; González-Rubio S; Hidalgo AB; Díaz-López C; Costán G; Padillo FJ; De la Mata M; Ochoa B; Muntané J
    Innate Immun; 2009 Dec; 15(6):337-49. PubMed ID: 19710104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis.
    Dong YQ; Zhang XZ; Sun LL; Zhang SY; Liu B; Liu HY; Wang X; Jiang CT
    Acta Pharmacol Sin; 2017 Dec; 38(12):1601-1610. PubMed ID: 28933423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.
    Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
    Hepatology; 2008 Sep; 48(3):770-81. PubMed ID: 18752326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
    Alwayn IP; Gura K; Nosé V; Zausche B; Javid P; Garza J; Verbesey J; Voss S; Ollero M; Andersson C; Bistrian B; Folkman J; Puder M
    Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes.
    Liang H; Zhang L; Wang H; Tang J; Yang J; Wu C; Chen S
    Int J Mol Sci; 2015 Nov; 16(11):27749-56. PubMed ID: 26610473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.